HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Forsythiaside inhibits cigarette smoke-induced lung inflammation by activation of Nrf2 and inhibition of NF-κB.

Abstract
Cigarette smoke has been reported to be the major cause of chronic obstructive pulmonary disease (COPD). It causes persistent inflammation by regulating the redox-sensitive pathways. Forsythiaside, an active constituent isolated from the Chinese medicinal herb Forsythia suspensa, has been reported to have anti-inflammatory and anti-oxidant effects. Thus, in this study, we investigated the protective effects of forsythiaside against cigarette smoke-induced lung inflammation in mice. COPD mice model was established by cigarette smoke. Forsythiaside was given 2h before cigarette smoke exposure for five consecutive days. Bronchoalveolar lavage fluid and lung tissues were collected to assess pathological changes, lipid peroxidation, inflammatory cytokine production, Nrf-2, and NF-κB expression. Our results showed that forsythiaside attenuated the infiltration of inflammatory cells, NO and inflammatory cytokines TNF-α, IL-6 and IL-1β production, and reversed the CS-induced decrease of glutathione/glutathione disulfide (GSH/GSSG) ratio. Western blot analysis showed that forsythiaside inhibited cigarette smoke-induced NF-κB activation. In addition, forsythiaside dose-dependently up-regulated the expression of Nrf2 and HO-1. In conclusion, forsythiaside protected against cigarette smoke-induced lung injury through activating Nrf2 and inhibiting NF-κB signaling pathway.
AuthorsLi Cheng, Fan Li, Rui Ma, Xianping Hu
JournalInternational immunopharmacology (Int Immunopharmacol) Vol. 28 Issue 1 Pg. 494-9 (Sep 2015) ISSN: 1878-1705 [Electronic] Netherlands
PMID26209933 (Publication Type: Journal Article)
CopyrightCopyright © 2015 Elsevier B.V. All rights reserved.
Chemical References
  • Anti-Inflammatory Agents
  • Cytokines
  • Glycosides
  • Membrane Proteins
  • NF-E2-Related Factor 2
  • NF-kappa B
  • Nfe2l2 protein, mouse
  • Smoke
  • Nitric Oxide
  • Heme Oxygenase-1
  • Hmox1 protein, mouse
  • forsythiaside
Topics
  • Animals
  • Anti-Inflammatory Agents (pharmacology, therapeutic use)
  • Bronchoalveolar Lavage Fluid (cytology, immunology)
  • Cell Count
  • Cytokines (immunology)
  • Glycosides (pharmacology, therapeutic use)
  • Heme Oxygenase-1 (metabolism)
  • Lung (drug effects, pathology, physiopathology)
  • Male
  • Membrane Proteins (metabolism)
  • Mice, Inbred C57BL
  • NF-E2-Related Factor 2 (metabolism)
  • NF-kappa B (antagonists & inhibitors, metabolism)
  • Nitric Oxide (metabolism)
  • Pneumonia (drug therapy, metabolism, pathology, physiopathology)
  • Smoke (adverse effects)
  • Spirometry
  • Tobacco

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: